Digital conference for early-stage life science companies which are pioneering the development of assets from universities and other sources with a view to creating innovative medicines. This year's conference will give delegates information about financing new assets and advancing them through R&D collaborations.
News - Events
SMi's 14th annual meeting on pre-filled syringes will discuss what the future holds for this industry as well as the combination products industry. Among topics will be lessons learned from the Covid-19 pandemic and how the industry is coping with the delayed launch of the EU Medical Devices Regulation. Delegates will also discuss how pharma, developers of medical devices, and regulators can work together to encourage innovation.
SMi's flagship microbiology conference will be celebrating its 10th anniversary at the start of 2022 with a meeting chaired by Di Morris, clinical auditor of AstraZeneca Plc.
The inaugural Transdermal and Microneedle Drug Delivery Conference will explore real-world applications of microneedles in drug delivery and strategies for device design. It will include case studies from those experienced in the field. The conference will look at innovations in microneedle technology for a Covid-19 vaccine, opportunities for cancer vaccine delivery, microarray patches, and microneedle-based diagnostics.
SMi's 3D Cell Culture Conference will explore advances in the application of 3D cell models, from their employment in drug screening to reduce candidate attrition, to the latest insights into microphysiological systems, the regulatory landscape and the clinical applications of 3D bioprinting. The conference is being sponsored by CelVivo and Promega.
The RNA therapeutics industry has grown at an exponential rate in recent years highlighted by the recent launch of messenger RNA (mRNA) vaccines to prevent Covid-19. This year's conference will consider how the industry has adapted to these developments and discuss future mRNA therapeutics. The 2022 agenda will explore innovations in targeted RNA delivery, opportunities for RNAi and the landscape for antisense oligonucleotides.
At this inaugural conference, speakers will showcase the latest developments in harnessing and integrating robotic hardware and automation solutions in pharma, from advancements in artificial intelligence and machine learning, to key insights into data and analytics, as well as the significant leaps in the robotic automation of some of pharma's most crucial processes.
Join us at SMi's 3rd annual AI in Drug Discovery conference and explore the latest industry updates in: the selection of targets using AI; decision-making within drug discovery; and closing the loop on AI in drug discovery. The meeting will feature presentations from leaders in the field who will share their insights into the latest advances in technology.
This event provides a unique opportunity for industry experts to come together and share perspectives on the practice of parallel trade. Parallel trade is a type of commerce in which wholesalers can buy medicinal products in one member state of the European Union, where prices are low, and sell the same products in another member state, where prices are higher. This form of arbitrage has been declared legal by the European Court of Justice.